| 111 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 112 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 113 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 114 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 115 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 116 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 117 |
1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
|
2018 |
| 118 |
1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
|
2018 |
| 119 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 120 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
